Clinical trial
Open Comparative Study With a Cross-over According to Patients'Preference Receiving Xeloda or UFT With Folinic Acid in Advanced or Metastatic Colo-rectal Cancer
NCT00905047 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open Comparative Study With a Cross-over According to Patients'Preference Receiving Xeloda or UFT With Folinic Acid in Advanced or Metastatic Colo-rectal Cancer
- Lead sponsor
- Centre Oscar Lambret
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 14, 2005
- Completion date
- September 30, 2011
- Enrollment
- 89 (actual)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer